_id
691727f03c536f8df2316c4c
Ticker
VCNX
Name
Vaccinex Inc
Exchange
PINK
Address
1895 Mount Hope Avenue, Rochester, NY, United States, 14620
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.vaccinex.com
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate is pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. It is developing Pepinemab, which is in phase 2 clinical for the treatment of Alzheimer's disease and has completed phase 2 study for the treatment of Huntington's disease; Pepinemab in combination with Pembrolizumab in phase 2 study for head and neck cancer; Pepinemab in combination with Avelumab in phase 2 study for pancreatic cancer, and completed phase 2 clinical trial with Avelumab for non-small cell lung cancer; and Pepinemab in combination with Nivolumab and/or Ipilimumab which is in phase 2 clinical trial for melanoma; Pepinemab in combination with Trastuzumab and dendritic cell vaccines in phase 2 clinical trial for breast cancer. The company has also developed ActivMAb, a human antibody discovery platform based on a novel method for expressing and presenting complex multipass membrane proteins, as well as full-length human monoclonal antibodies on the surface of mammalian pox viruses. In addition, it develops CHS-114 and anti-CCR8 antibody; and VX5, which is in preclinical development to treat related to autoimmune disorders.It has collaborations with Merck Sharp & Dohme; Ares Trading S.A.; Emory University; Huntington Study Group; Catalent Pharma Solutions, LLC; and Surface Oncology, Inc. The company was incorporated in 2001 and is headquartered in Rochester, New York.
Last Close
0.67
Volume
2
Current Price
0.5
Change
-25.373134328358216
Last Updated
2025-12-04T14:57:43.491Z
Image
https://logo.clearbit.com/www.vaccinex.com
Ipo Date
2018-08-09T00:00:00.000Z
Market Cap
1846879
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
7
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-03-31
Revenue
213000
Cost Of Revenue
-
Gross Profit
213000
Operating Expenses
3600000
Operating Income
-3387000
Interest Expense
2000
Pretax Income
-3374000
Net Income
-3374000
Eps
-1.6074726994059403
Dividends Per Share
-
Shares Outstanding
2676637
Income Tax Expense
-
EBITDA
-3355000
Operating Margin
-1590.1408450704225
Total Other Income Expense Net
13000
Cash
1107000
Short Term Investments
-
Receivables
838000
Inventories
-
Total Current Assets
2531000
Property Plant Equipment
65000
Total Assets
2596000
Payables
3955000
Short Term Debt
25000
Long Term Debt
-
Total Liabilities
5084000
Equity
-2488000
Depreciation
17000
Change In Working Capital
-646000
Cash From Operations
-3932000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2133000
Net Change In Cash
-1799000
PE
-
PB
-0.4218141077170418
ROE
135.61093247588425
ROA
-129.96918335901387
FCF
-3932000
Fcf Percent
-18.460093896713616
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
1.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-03-31
Quarters > 0 > income Statement > revenue
213000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
213000
Quarters > 0 > income Statement > operating Expenses
3600000
Quarters > 0 > income Statement > operating Income
-3387000
Quarters > 0 > income Statement > interest Expense
2000
Quarters > 0 > income Statement > pretax Income
-3374000
Quarters > 0 > income Statement > net Income
-3374000
Quarters > 0 > income Statement > eps
-1.6074726994059403
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2098947
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3355000
Quarters > 0 > income Statement > operating Margin
-1590.1408450704225
Quarters > 0 > income Statement > total Other Income Expense Net
13000
Quarters > 0 > balance Sheet > cash
1107000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
838000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2531000
Quarters > 0 > balance Sheet > property Plant Equipment
65000
Quarters > 0 > balance Sheet > total Assets
2596000
Quarters > 0 > balance Sheet > payables
3955000
Quarters > 0 > balance Sheet > short Term Debt
25000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5084000
Quarters > 0 > balance Sheet > equity
-2488000
Quarters > 0 > cash Flow > net Income
-3374000
Quarters > 0 > cash Flow > depreciation
17000
Quarters > 0 > cash Flow > change In Working Capital
-646000
Quarters > 0 > cash Flow > cash From Operations
-3932000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2133000
Quarters > 0 > cash Flow > net Change In Cash
-1799000
Quarters > 0 > ratios > PE
-1.6074726994059403
Quarters > 0 > ratios > PB
-0.4218141077170418
Quarters > 0 > ratios > ROE
135.61093247588425
Quarters > 0 > ratios > ROA
-129.96918335901387
Quarters > 0 > ratios > FCF
-3932000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-18.460093896713616
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
213000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
3600000
Quarters > 1 > income Statement > operating Income
-3387000
Quarters > 1 > income Statement > interest Expense
2000
Quarters > 1 > income Statement > pretax Income
-3374000
Quarters > 1 > income Statement > net Income
-3374000
Quarters > 1 > income Statement > eps
-1.2605370096879032
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2676637
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-1590.1408450704225
Quarters > 1 > income Statement > total Other Income Expense Net
15000
Quarters > 1 > balance Sheet > cash
1107000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
838000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2531000
Quarters > 1 > balance Sheet > property Plant Equipment
65000
Quarters > 1 > balance Sheet > total Assets
2596000
Quarters > 1 > balance Sheet > payables
3955000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5084000
Quarters > 1 > balance Sheet > equity
-2488000
Quarters > 1 > cash Flow > net Income
-3374000
Quarters > 1 > cash Flow > depreciation
17000
Quarters > 1 > cash Flow > change In Working Capital
-646000
Quarters > 1 > cash Flow > cash From Operations
-3932000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2133000
Quarters > 1 > cash Flow > net Change In Cash
-1799000
Quarters > 1 > ratios > PE
-1.2605370096879032
Quarters > 1 > ratios > PB
-0.5379093649517684
Quarters > 1 > ratios > ROE
135.61093247588425
Quarters > 1 > ratios > ROA
-129.96918335901387
Quarters > 1 > ratios > FCF
-3932000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-18.460093896713616
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
52000
Quarters > 2 > income Statement > cost Of Revenue
24000
Quarters > 2 > income Statement > gross Profit
52000
Quarters > 2 > income Statement > operating Expenses
4604000
Quarters > 2 > income Statement > operating Income
-4552000
Quarters > 2 > income Statement > interest Expense
0
Quarters > 2 > income Statement > pretax Income
-5732000
Quarters > 2 > income Statement > net Income
-5732000
Quarters > 2 > income Statement > eps
-2.8279359816864997
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2026920
Quarters > 2 > income Statement > income Tax Expense
-5732000
Quarters > 2 > income Statement > EBITDA
-5708000
Quarters > 2 > income Statement > operating Margin
-8753.846153846152
Quarters > 2 > income Statement > total Other Income Expense Net
-1180000
Quarters > 2 > balance Sheet > cash
2906000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
985000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4757000
Quarters > 2 > balance Sheet > property Plant Equipment
97000
Quarters > 2 > balance Sheet > total Assets
4854000
Quarters > 2 > balance Sheet > payables
4865000
Quarters > 2 > balance Sheet > short Term Debt
59000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6175000
Quarters > 2 > balance Sheet > equity
-1321000
Quarters > 2 > cash Flow > net Income
-5732000
Quarters > 2 > cash Flow > depreciation
24000
Quarters > 2 > cash Flow > change In Working Capital
1248000
Quarters > 2 > cash Flow > cash From Operations
-3207000
Quarters > 2 > cash Flow > capital Expenditures
8000
Quarters > 2 > cash Flow > cash From Investing
-8000
Quarters > 2 > cash Flow > cash From Financing
5888000
Quarters > 2 > cash Flow > net Change In Cash
2673000
Quarters > 2 > ratios > PE
-2.8279359816864997
Quarters > 2 > ratios > PB
-0.7671915215745647
Quarters > 2 > ratios > ROE
433.9137017411052
Quarters > 2 > ratios > ROA
-118.08817470127731
Quarters > 2 > ratios > FCF
-3215000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-61.82692307692308
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
232000
Quarters > 3 > income Statement > cost Of Revenue
25000
Quarters > 3 > income Statement > gross Profit
232000
Quarters > 3 > income Statement > operating Expenses
5954000
Quarters > 3 > income Statement > operating Income
-5722000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-5631000
Quarters > 3 > income Statement > net Income
-5631000
Quarters > 3 > income Statement > eps
-3.0981777366961576
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1817520
Quarters > 3 > income Statement > income Tax Expense
-5747000
Quarters > 3 > income Statement > EBITDA
-5606000
Quarters > 3 > income Statement > operating Margin
-2466.379310344828
Quarters > 3 > income Statement > total Other Income Expense Net
91000
Quarters > 3 > balance Sheet > cash
233000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1045000
Quarters > 3 > balance Sheet > inventories
1
Quarters > 3 > balance Sheet > total Current Assets
2202000
Quarters > 3 > balance Sheet > property Plant Equipment
165000
Quarters > 3 > balance Sheet > total Assets
2367000
Quarters > 3 > balance Sheet > payables
3243000
Quarters > 3 > balance Sheet > short Term Debt
122000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5231000
Quarters > 3 > balance Sheet > equity
-2864000
Quarters > 3 > cash Flow > net Income
-5631000
Quarters > 3 > cash Flow > depreciation
26000
Quarters > 3 > cash Flow > change In Working Capital
1153000
Quarters > 3 > cash Flow > cash From Operations
-4415000
Quarters > 3 > cash Flow > capital Expenditures
14000
Quarters > 3 > cash Flow > cash From Investing
-14000
Quarters > 3 > cash Flow > cash From Financing
1690000
Quarters > 3 > cash Flow > net Change In Cash
-2739000
Quarters > 3 > ratios > PE
-3.0981777366961576
Quarters > 3 > ratios > PB
-0.317304469273743
Quarters > 3 > ratios > ROE
196.6131284916201
Quarters > 3 > ratios > ROA
-237.8960709759189
Quarters > 3 > ratios > FCF
-4429000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-19.09051724137931
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
601000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
601000
Annuals > 0 > income Statement > operating Expenses
19336000
Annuals > 0 > income Statement > operating Income
-18735000
Annuals > 0 > income Statement > interest Expense
2000
Annuals > 0 > income Statement > pretax Income
-18634000
Annuals > 0 > income Statement > net Income
-18634000
Annuals > 0 > income Statement > eps
-8.877784908337372
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2098947
Annuals > 0 > income Statement > income Tax Expense
-18634000
Annuals > 0 > income Statement > EBITDA
-18538000
Annuals > 0 > income Statement > operating Margin
-3117.304492512479
Annuals > 0 > income Statement > total Other Income Expense Net
101000
Annuals > 0 > balance Sheet > cash
1107000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
838000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2531000
Annuals > 0 > balance Sheet > property Plant Equipment
65000
Annuals > 0 > balance Sheet > total Assets
2596000
Annuals > 0 > balance Sheet > payables
3955000
Annuals > 0 > balance Sheet > short Term Debt
25000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5084000
Annuals > 0 > balance Sheet > equity
-2488000
Annuals > 0 > cash Flow > net Income
-18634000
Annuals > 0 > cash Flow > depreciation
94000
Annuals > 0 > cash Flow > change In Working Capital
2103000
Annuals > 0 > cash Flow > cash From Operations
-16186000
Annuals > 0 > cash Flow > capital Expenditures
22000
Annuals > 0 > cash Flow > cash From Investing
-22000
Annuals > 0 > cash Flow > cash From Financing
15780000
Annuals > 0 > cash Flow > net Change In Cash
-428000
Annuals > 0 > ratios > PE
-8.877784908337372
Annuals > 0 > ratios > PB
-0.5462492694935691
Annuals > 0 > ratios > ROE
748.9549839228296
Annuals > 0 > ratios > ROA
-717.7966101694915
Annuals > 0 > ratios > FCF
-16208000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-26.96838602329451
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
570000
Annuals > 1 > income Statement > cost Of Revenue
119000
Annuals > 1 > income Statement > gross Profit
570000
Annuals > 1 > income Statement > operating Expenses
23455000
Annuals > 1 > income Statement > operating Income
-22885000
Annuals > 1 > income Statement > interest Expense
1000
Annuals > 1 > income Statement > pretax Income
-20251000
Annuals > 1 > income Statement > net Income
-20251000
Annuals > 1 > income Statement > eps
-43.6773428232503
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
463650
Annuals > 1 > income Statement > income Tax Expense
-48895
Annuals > 1 > income Statement > EBITDA
-19748000
Annuals > 1 > income Statement > operating Margin
-4014.9122807017543
Annuals > 1 > income Statement > total Other Income Expense Net
2634000
Annuals > 1 > balance Sheet > cash
1535000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
961000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3349000
Annuals > 1 > balance Sheet > property Plant Equipment
282000
Annuals > 1 > balance Sheet > total Assets
3631000
Annuals > 1 > balance Sheet > payables
2039000
Annuals > 1 > balance Sheet > short Term Debt
221000
Annuals > 1 > balance Sheet > long Term Debt
26000
Annuals > 1 > balance Sheet > total Liabilities
5942000
Annuals > 1 > balance Sheet > equity
-2311000
Annuals > 1 > cash Flow > net Income
-20251000
Annuals > 1 > cash Flow > depreciation
119000
Annuals > 1 > cash Flow > change In Working Capital
318000
Annuals > 1 > cash Flow > cash From Operations
-17234000
Annuals > 1 > cash Flow > capital Expenditures
67000
Annuals > 1 > cash Flow > cash From Investing
-67000
Annuals > 1 > cash Flow > cash From Financing
12445000
Annuals > 1 > cash Flow > net Change In Cash
-4856000
Annuals > 1 > ratios > PE
-43.6773428232503
Annuals > 1 > ratios > PB
-0.12990626352228474
Annuals > 1 > ratios > ROE
876.2873215058416
Annuals > 1 > ratios > ROA
-557.7251445882677
Annuals > 1 > ratios > FCF
-17301000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-30.352631578947367
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
100000
Annuals > 2 > income Statement > cost Of Revenue
207000
Annuals > 2 > income Statement > gross Profit
68000
Annuals > 2 > income Statement > operating Expenses
20006000
Annuals > 2 > income Statement > operating Income
-19906000
Annuals > 2 > income Statement > interest Expense
2000
Annuals > 2 > income Statement > pretax Income
-19815000
Annuals > 2 > income Statement > net Income
-19722000
Annuals > 2 > income Statement > eps
-97.5940459813343
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
202082
Annuals > 2 > income Statement > income Tax Expense
-93000
Annuals > 2 > income Statement > EBITDA
-19606000
Annuals > 2 > income Statement > operating Margin
-19906
Annuals > 2 > income Statement > total Other Income Expense Net
91000
Annuals > 2 > balance Sheet > cash
6391000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
175000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
7478000
Annuals > 2 > balance Sheet > property Plant Equipment
499000
Annuals > 2 > balance Sheet > total Assets
7977000
Annuals > 2 > balance Sheet > payables
1518000
Annuals > 2 > balance Sheet > short Term Debt
238000
Annuals > 2 > balance Sheet > long Term Debt
101000
Annuals > 2 > balance Sheet > total Liabilities
2784000
Annuals > 2 > balance Sheet > equity
5193000
Annuals > 2 > cash Flow > net Income
-19815000
Annuals > 2 > cash Flow > depreciation
207000
Annuals > 2 > cash Flow > change In Working Capital
-11000
Annuals > 2 > cash Flow > cash From Operations
-19074000
Annuals > 2 > cash Flow > capital Expenditures
99000
Annuals > 2 > cash Flow > cash From Investing
-99000
Annuals > 2 > cash Flow > cash From Financing
16975000
Annuals > 2 > cash Flow > net Change In Cash
-2198000
Annuals > 2 > ratios > PE
-97.5940459813343
Annuals > 2 > ratios > PB
0.025197014249951855
Annuals > 2 > ratios > ROE
-379.7804737146158
Annuals > 2 > ratios > ROA
-247.2358029334336
Annuals > 2 > ratios > FCF
-19173000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-191.73
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
900000
Annuals > 3 > income Statement > cost Of Revenue
169000
Annuals > 3 > income Statement > gross Profit
731000
Annuals > 3 > income Statement > operating Expenses
23221000
Annuals > 3 > income Statement > operating Income
-22490000
Annuals > 3 > income Statement > interest Expense
809000
Annuals > 3 > income Statement > pretax Income
-22380000
Annuals > 3 > income Statement > net Income
-22380000
Annuals > 3 > income Statement > eps
-162.90936619667048
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
137377
Annuals > 3 > income Statement > income Tax Expense
852000
Annuals > 3 > income Statement > EBITDA
-21402000
Annuals > 3 > income Statement > operating Margin
-2498.8888888888887
Annuals > 3 > income Statement > total Other Income Expense Net
110000
Annuals > 3 > balance Sheet > cash
8589000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
9405000
Annuals > 3 > balance Sheet > property Plant Equipment
438000
Annuals > 3 > balance Sheet > total Assets
9843000
Annuals > 3 > balance Sheet > payables
1061000
Annuals > 3 > balance Sheet > short Term Debt
215000
Annuals > 3 > balance Sheet > long Term Debt
175000
Annuals > 3 > balance Sheet > total Liabilities
2431000
Annuals > 3 > balance Sheet > equity
7412000
Annuals > 3 > cash Flow > net Income
-22380000
Annuals > 3 > cash Flow > depreciation
169000
Annuals > 3 > cash Flow > change In Working Capital
-3210000
Annuals > 3 > cash Flow > cash From Operations
-25298000
Annuals > 3 > cash Flow > capital Expenditures
32000
Annuals > 3 > cash Flow > cash From Investing
-32000
Annuals > 3 > cash Flow > cash From Financing
23323000
Annuals > 3 > cash Flow > net Change In Cash
-2007000
Annuals > 3 > ratios > PE
-162.90936619667048
Annuals > 3 > ratios > PB
0.012001026376146789
Annuals > 3 > ratios > ROE
-301.9427954668106
Annuals > 3 > ratios > ROA
-227.3697043584273
Annuals > 3 > ratios > FCF
-25330000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-28.144444444444446
Annuals > 3 > health Score
34
Valuation > metrics > PE
-1.6074726994059403
Valuation > metrics > PB
-0.4218141077170418
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
135.61093247588425
Profitability > metrics > ROA
-133.30699328328723
Profitability > metrics > Net Margin
-15.84037558685446
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1693.5
Risk > final Score
-6744
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.635929648241206
Liquidity > metrics > Quick Ratio
0.635929648241206
Liquidity > final Score
42
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-6744
Prev Risks > 1
-729
Prev Risks > 2
-886
Prev Liquidities > 0
42
Prev Liquidities > 1
58
Prev Liquidities > 2
43
Updated At
2025-12-14T01:22:47.110Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-05-09
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-1.2605
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-09-30
Earnings History > 1 > report Date
2024-11-11
Earnings History > 1 > date
2024-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-2.8279
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-08-12
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-3.0982
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-03-31
Earnings History > 3 > report Date
2024-04-02
Earnings History > 3 > date
2024-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-3.7161
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-09-30
Earnings History > 4 > report Date
2023-11-13
Earnings History > 4 > date
2023-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.09
Earnings History > 4 > eps Estimate
-0.2608
Earnings History > 4 > eps Difference
-0.8292
Earnings History > 4 > surprise Percent
-317.9448
Earnings History > 5 > period
2023-06-30
Earnings History > 5 > report Date
2023-08-14
Earnings History > 5 > date
2023-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.21
Earnings History > 5 > eps Estimate
-0.29
Earnings History > 5 > eps Difference
0.08
Earnings History > 5 > surprise Percent
27.5862
Earnings History > 6 > period
2023-03-31
Earnings History > 6 > report Date
2023-05-15
Earnings History > 6 > date
2023-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.21
Earnings History > 6 > eps Estimate
-0.29
Earnings History > 6 > eps Difference
0.08
Earnings History > 6 > surprise Percent
27.5862
Earnings History > 7 > period
2022-12-31
Earnings History > 7 > report Date
2023-03-31
Earnings History > 7 > date
2022-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1106
Earnings History > 7 > eps Estimate
-0.2694
Earnings History > 7 > eps Difference
0.1588
Earnings History > 7 > surprise Percent
58.9458
Earnings History > 8 > period
2022-09-30
Earnings History > 8 > report Date
2022-11-14
Earnings History > 8 > date
2022-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.11
Earnings History > 8 > eps Estimate
-0.27
Earnings History > 8 > eps Difference
0.16
Earnings History > 8 > surprise Percent
59.2593
Earnings History > 9 > period
2022-06-30
Earnings History > 9 > report Date
2022-08-15
Earnings History > 9 > date
2022-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.13
Earnings History > 9 > eps Estimate
-0.27
Earnings History > 9 > eps Difference
0.14
Earnings History > 9 > surprise Percent
51.8519
Earnings History > 10 > period
2022-03-31
Earnings History > 10 > report Date
2022-05-16
Earnings History > 10 > date
2022-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.12
Earnings History > 10 > eps Estimate
-0.27
Earnings History > 10 > eps Difference
0.15
Earnings History > 10 > surprise Percent
55.5556
Earnings History > 11 > period
2021-12-31
Earnings History > 11 > report Date
2022-03-31
Earnings History > 11 > date
2021-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.17
Earnings History > 11 > eps Estimate
-0.3
Earnings History > 11 > eps Difference
0.13
Earnings History > 11 > surprise Percent
43.3333
Earnings History > 12 > period
2021-09-30
Earnings History > 12 > report Date
2021-11-08
Earnings History > 12 > date
2021-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.17
Earnings History > 12 > eps Estimate
-0.29
Earnings History > 12 > eps Difference
0.12
Earnings History > 12 > surprise Percent
41.3793
Earnings History > 13 > period
2021-06-30
Earnings History > 13 > report Date
2021-08-16
Earnings History > 13 > date
2021-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.21
Earnings History > 13 > eps Estimate
-0.29
Earnings History > 13 > eps Difference
0.08
Earnings History > 13 > surprise Percent
27.5862
Earnings History > 14 > period
2021-03-31
Earnings History > 14 > report Date
2021-05-17
Earnings History > 14 > date
2021-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.26
Earnings History > 14 > eps Estimate
-0.26
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2020-12-31
Earnings History > 15 > report Date
2021-03-31
Earnings History > 15 > date
2020-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.29
Earnings History > 15 > eps Estimate
-0.37
Earnings History > 15 > eps Difference
0.08
Earnings History > 15 > surprise Percent
21.6216
Earnings History > 16 > period
2020-09-30
Earnings History > 16 > report Date
2020-11-13
Earnings History > 16 > date
2020-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.44
Earnings History > 16 > eps Estimate
-0.43
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-2.3256
Earnings History > 17 > period
2020-06-30
Earnings History > 17 > report Date
2020-08-14
Earnings History > 17 > date
2020-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.39
Earnings History > 17 > eps Estimate
-0.51
Earnings History > 17 > eps Difference
0.12
Earnings History > 17 > surprise Percent
23.5294
Earnings History > 18 > period
2020-03-31
Earnings History > 18 > report Date
2020-05-14
Earnings History > 18 > date
2020-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.45
Earnings History > 18 > eps Estimate
-0.75
Earnings History > 18 > eps Difference
0.3
Earnings History > 18 > surprise Percent
40
Earnings History > 19 > period
2019-12-31
Earnings History > 19 > report Date
2020-03-09
Earnings History > 19 > date
2019-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.38
Earnings History > 19 > eps Estimate
-0.58
Earnings History > 19 > eps Difference
0.2
Earnings History > 19 > surprise Percent
34.4828
Earnings History > 20 > period
2019-09-30
Earnings History > 20 > report Date
2019-11-12
Earnings History > 20 > date
2019-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.56
Earnings History > 20 > eps Estimate
-0.66
Earnings History > 20 > eps Difference
0.1
Earnings History > 20 > surprise Percent
15.1515
Earnings History > 21 > period
2019-06-30
Earnings History > 21 > report Date
2019-08-14
Earnings History > 21 > date
2019-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.77
Earnings History > 21 > eps Estimate
-0.7
Earnings History > 21 > eps Difference
-0.07
Earnings History > 21 > surprise Percent
-10
Earnings History > 22 > period
2019-03-31
Earnings History > 22 > report Date
2019-05-15
Earnings History > 22 > date
2019-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.79
Earnings History > 22 > eps Estimate
-0.75
Earnings History > 22 > eps Difference
-0.04
Earnings History > 22 > surprise Percent
-5.3333
Earnings History > 23 > period
2018-12-31
Earnings History > 23 > report Date
2019-03-13
Earnings History > 23 > date
2018-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.73
Earnings History > 23 > eps Estimate
-0.94
Earnings History > 23 > eps Difference
0.21
Earnings History > 23 > surprise Percent
22.3404
Earnings History > 24 > period
2018-09-30
Earnings History > 24 > report Date
2018-11-13
Earnings History > 24 > date
2018-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.93
Earnings History > 24 > eps Estimate
-0.64
Earnings History > 24 > eps Difference
-0.29
Earnings History > 24 > surprise Percent
-45.3125
Earnings History > 25 > period
2018-06-30
Earnings History > 25 > report Date
2018-08-14
Earnings History > 25 > date
2018-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.91
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-03-31
Earnings History > 26 > report Date
2018-05-30
Earnings History > 26 > date
2018-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.78
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.78
Earnings History > 26 > surprise Percent
-
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate is pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. It is developing Pepinemab, which is in phase 2 clinical for the treatment of Alzheimer's disease and has completed phase 2 study for the treatment of Huntington's disease; Pepinemab in combination with Pembrolizumab in phase 2 study for head and neck cancer; Pepinemab in combination with Avelumab in phase 2 study for pancreatic cancer, and completed phase 2 clinical trial with Avelumab for non-small cell lung cancer; and Pepinemab in combination with Nivolumab and/or Ipilimumab which is in phase 2 clinical trial for melanoma; Pepinemab in combination with Trastuzumab and dendritic cell vaccines in phase 2 clinical trial for breast cancer. The company has also developed ActivMAb, a human antibody discovery platform based on a novel method for expressing and presenting complex multipass membrane proteins, as well as full-length human monoclonal antibodies on the surface of mammalian pox viruses. In addition, it develops CHS-114 and anti-CCR8 antibody; and VX5, which is in preclinical development to treat related to autoimmune disorders.It has collaborations with Merck Sharp & Dohme; Ares Trading S.A.; Emory University; Huntington Study Group; Catalent Pharma Solutions, LLC; and Surface Oncology, Inc. The company was incorporated in 2001 and is headquartered in Rochester, New York.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACan Vaccinex Survive After Nasdaq Exit? Key Details on Company's Future Strategy - Stock Titan
3/7/2025
Can Vaccinex Survive After Nasdaq Exit? Key Details on Company's Future Strategy Stock Titan
Read more →Vaccinex, Inc. Faces Delisting from Nasdaq Due to Failure to Meet Continued Listing Standards Nasdaq
Read more →Showing 2 of 10
(Last Updated 2025-03-31)
Rating:
BUY
Target Price:
$7
Analyst Picks
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.01% of the total shares of Vaccinex Inc
1.
Advisor Group Holdings, Inc.(0.002%)
since
2024/12/31
2.
Barclays PLC(0.0017%)
since
2024/12/31
3.
Royal Bank of Canada(0.0014%)
since
2024/09/30
4.
SSgA U.S. Total Market Index Strategy(0.0013%)
since
2024/06/30
5.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0004%)
since
2024/09/30
6.
Capital Advisors, Ltd. LLC(0.0001%)
since
2024/09/30
7.
Wells Fargo & Co(0%)
since
2024/12/31
8.
AIGH Capital Management, LLC(0%)
since
2024/09/30
9.
Tower Research Capital LLC(0%)
since
2024/12/31
10.
Northern Trust Investments N A(0%)
since
2024/12/31
11.
UBS Group AG(0%)
since
2024/12/31
12.
Group One Trading, LP(0%)
since
2024/12/31
13.
Morgan Stanley - Brokerage Accounts(0%)
since
2024/12/31
14.
Armistice Capital, LLC(0%)
since
2024/12/31
15.
Bank of America Corp(0%)
since
2024/12/31
16.
Point72 Asset Management, L.P.(0%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-1.2605
EPS Estimate
—
EPS Difference
0
Surprise Percent
null%
(Last Updated 2025-03-31)
(Last Updated 2025-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.